The past week has witnessed outflows worth $67.6 million from the iShares Nasdaq Biotechnology Index Fund, ETF Channel reports. The outflows are 3.9% lower than those in the previous week.

The outflows mark a reduction from 16,750,000 to 16,100,000. Among the biggest underlying components of the iShares fund, Amgen’s trading decreased by nearly 1.6% and Pharmasset declined by almost 0.9%.

Click here for the story from ETF Channel.